David A. Melnick
Chief Medical Officer, Spero Therapeutics, Inc.
Companies
- Spero Therapeutics, Inc.Chief Medical Officer Jan 5, 2018 to Feb 3, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Spero Therapeutics, Inc. SPRO62,081 shares2$70.8K at $1.14Feb 1, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 1, 2022Granted 38,014 shares of Spero Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2